课题基金 / 基金详情

Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk

Undernutrition-helminth-alcohol interactions, placental mechanisms, and FASD risk
营养不良-蠕虫-酒精相互作用、胎盘机制和 FASD 风险
批准号:
9104456
负责人:
JENNIFER F FRIEDMAN
金额:
$27.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-06 至 2020-12-31
关键词:
1 year oldAccountingAddressAffectAge-MonthsAlcohol consumptionAlcoholic BeveragesAlcoholsApoptosisAreaAsiansBiological AssayBirthBloodBlood CirculationComorbidityConsumptionCountryDNADNA DamageEndotoxinsEnrollmentEquationEtiologyFetal Alcohol ExposureFetal Alcohol Spectrum DisorderFetal GrowthFetal Growth RetardationFilipinoFundingGene TargetingGestational AgeGoalsGrowthHealthHelminthiasisHelminthsHistologicHybridsImmunohistochemistryImpairmentInfant DevelopmentInfant HealthInfectionInflammationInflammatoryInsulinIntakeInterventionJointsLow Birth Weight InfantMalnutritionMaternal-Fetal ExchangeMeasuresModelingModificationMolecularMorbidity - disease rateNeurocognitive DeficitNewborn InfantNutritional statusOutcomePathogenesisPathologyPathway interactionsPerinatalPhilippinesPlacentaPlacentationPraziquantelPregnancyPregnant WomenRandomized Controlled TrialsRecruitment ActivityReference StandardsReportingResearch InfrastructureResearch PersonnelRiskRisk FactorsSchistosomiasisSerumSignal TransductionSpottingsStructureTechniquesTrainingUmbilical Cord BloodUnited States National Institutes of HealthWeightWeight GainWineWomanadverse pregnancy outcomealcohol exposureattributable mortalitybaseburden of illnessdesigndisability-adjusted life yearsdisorder riskexperienceinfancyinfant outcomeinflammatory markerinnovationintestinal fatty acid binding proteinlow and middle-income countriesmaternal serummicrobialmortalityplacental morphologyprematureprenatal interventionpromoterpublic health relevance

项目摘要

项目成果

JENNIFER F FRIEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Low birth weight, particularly as a result of fetal growth restriction (FGR), disproportionately affects women residing in low and middle income countries (LMICs) and places newborns at increased risk of morbidity and mortality. In LMICs, FGR contributes more significantly to the burden of LBW than does prematurity. Despite this, significant lacunae remain with respect to our understanding of the etiology of FGR, hampering the design of rationale interventions to address this enormous burden. The overarching goals of this application are to 1) build an infrastructure for studies of alcohol and pregnancy in LMICs and 2) further our understanding of the mechanisms through which alcohol exposure interacts with other exposures unique to the LMIC setting to increase risk for adverse pregnancy outcomes seen in the context of fetal alcohol spectrum disorders, in particular FGR. FASDs are responsible for approximately 12.5% of alcohol-attributable deaths globally, with a significant portion of the global burden of disease is related to morbidity. In our recently completed NIH funded RCT of Praziquantel treatment during pregnancy, over 75% of subjects reported continued alcohol consumption at 12-16 weeks gestation. For the current application we will recruit N=400 women at 10-16 weeks gestation to examine the independent contribution of prevalent exposures in LMICs (alcohol, helminthiasis, undernutrition) and formally address whether these exposures interact to increase risk for adverse newborn and infant outcomes, in particular FGR (SA1). We hypothesize that each of these exposures will disrupt gut integrity, as we have demonstrated in the context of schistosomiasis, culminating in microbial translocation whereby endotoxin and other microbial products are detectable in the maternal systemic circulation and at the maternal fetal interface. In SA2, we will assess the placental mechanisms through which these exposures culminate in adverse birth outcomes, including a shift to a more pro-inflammatory placental micro-environment, disruptions in placentation captured with histologic and molecular techniques, and downmodulation of IGF pathways. In SA3, we will construct sophisticated Structural Equation Models to investigate how prevalent exposures impact placental health to ultimately contribute to the enormous global burden of disease due to FGR, growth stunting in infancy, and neurocognitive deficits at 12 months of age. Given the interdisciplinary expertise of co-investigators and the extensive experience of our field staff in Leyte, we are poised to rapidly initiate these innovative studies, which will inform pre-natal interventions to reduce these risks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development
  • 批准号:
    10632049
  • 项目类别:
  • 资助金额:
    $61.89万
  • 财政年份:
    2022
  • 负责人:
    JENNIFER F FRIEDMAN
  • 依托单位:
Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development
  • 批准号:
    10434390
  • 项目类别:
  • 资助金额:
    $63.2万
  • 财政年份:
    2022
  • 负责人:
    JENNIFER F FRIEDMAN
  • 依托单位:
Optimizing interventions to mitigate schistosomiasis-related morbidity among pregnant women and children
  • 批准号:
    10326849
  • 项目类别:
  • 资助金额:
    $19.08万
  • 财政年份:
    2015
  • 负责人:
    JENNIFER F FRIEDMAN
  • 依托单位:
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans
  • 批准号:
    9207123
  • 项目类别:
  • 资助金额:
    $15.83万
  • 财政年份:
    2015
  • 负责人:
    JENNIFER F FRIEDMAN
  • 依托单位:
海外基金